Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Getting Personal: Better Diagnosis, Better Treatment
Posted on September 8th, 2017 by Betsy Davis in Pharma R&D
Figures released by the U.S. National Cancer Institute (NCI) in 2017 indicate that the burden of cancer is on the rise, with the number of diagnoses rising by 50% over the next 13 years. Even more troubling is the predicted mortality rate for cancer, Continue reading “Getting Personal: Better Diagnosis, Better Treatment” »
Cancer Immunotherapy Webinar on September 12: Register Now
Posted on August 25th, 2017 by Patricia Morgan in Pharma R&D
After decades of being treated with a fairly typical combination of surgery and therapies, cancer is now being met with exciting new treatments that are more targeted and often less hard on the patient. Continue reading “Cancer Immunotherapy Webinar on September 12: Register Now” »
Making Precision Medicine a Reality
Posted on April 24th, 2017 by Thibault Geoui in Chemistry
Precision medicine is no longer just a promising new development discussed only by medical professionals and industry insiders at conferences and in journals. In early 2015, former U.S. President Barack Obama announced the $215 million Precision Medicine Initiative Continue reading “Making Precision Medicine a Reality” »
Making Medicine More Precise
Posted on March 13th, 2017 by Christy J. Wilson in Pharma R&D
Precision medicine, which takes the individual into account like never before, has been a thrilling development in the field of medicinal research. It is an area that has shown particular promise in the treatment of cancer, Continue reading “Making Medicine More Precise” »
